Skip to product information
1 of 1

Gene Bio Systems

PLCL1 Antibody, FITC conjugated - Cat. #: CSB-PA624015LC01HU

PLCL1 Antibody, FITC conjugated - Cat. #: CSB-PA624015LC01HU

SKU:CSB-PA624015LC01HU

Regular price $484.78 CAD
Regular price Sale price $484.78 CAD
Sale Sold out
Shipping calculated at checkout.

Size :50ug

Clone Number:

Aliases:Inactive phospholipase C-like protein 1 antibody; Inactive protein 1 antibody; Phospholipase C deleted in lung carcinoma antibody; Phospholipase C epsilon antibody; Phospholipase C like 1 antibody; Phospholipase C related but catalytically inactive protein antibody; Phospholipase C related, but catalytically inactive protein antibody; Phospholipase C-deleted in lung carcinoma antibody; Phospholipase C-related but catalytically inactive protein antibody; Phospholipase C-related catalytically antibody; PLC-L1 antibody; PLCE antibody; PLCL antibody; PLCL1 antibody; PLCL1_HUMAN antibody; PLDL1 antibody; PRIP antibody

Product Type:Polyclonal Antibody

Immunogen Species:Homo sapiens (Human)

UniProt ID:Q15111

Immunogen:Recombinant Human Inactive phospholipase C-like protein 1 protein (1-108AA)

Raised in:Rabbit

Species Reactivity:Human

Tested Applications:

Background:Involved in an inositol phospholipid-based intracellular signaling cascade. Shows no PLC activity to phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol. Component in the phospho-dependent endocytosis process of GABA A receptor (By similarity). Regulates the turnover of receptors and thus contributes to the maintenance of GABA-mediated synaptic inhibition. Its aberrant expression could contribute to the genesis and progression of lung carcinoma. Acts as an inhibitor of PPP1C.

Clonality:Polyclonal

Isotype:IgG

Purification Method:>95%, Protein G purified

Conjugate:FITC

Buffer:Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4

Form:Liquid

Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Names:PLCL1

Research Areas:Signal transduction

View full details